Success Metrics

Clinical Success Rate

85.7%

Based on 12 completed trials

Completion Rate

86%(12/14)

Active Trials

0(0%)

Results Posted

58%(7 trials)

Terminated

2(13%)

Phase Distribution

Ph not_applicable

33%

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 4Post-market surveillance

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

12 of 15 finished

Non-Completion Rate

20.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(12)

Terminated(3)

Detailed Status

Completed12

Terminated2

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (16.7%)

N/A5 (83.3%)

Trials by Status

terminated213%

completed1280%

withdrawn17%

Recent Activity

0 active trials

Showing 5 of 15

completed

Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)

NCT06138756

completedphase_4

Nerivio Efficacy by Time of Treatment Onset

NCT06976723

View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials

NCT05443659

Real-world Data Analysis of REN Treatment in Adolescence With Migraine

Completed

NCT05730556Not Applicable

A Study of Remote Electrical Neuromodulation for Acute Procedural Pain

Terminated

NCT05464069

Safety of Nerivio in Pregnant Women With Migraine

Completed

NCT06138756

Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)

Completed

NCT06976723Phase 4

Nerivio Efficacy by Time of Treatment Onset

Completed

NCT05310227Not Applicable

Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)

Withdrawn

NCT06738056

Nerivio Long-term Usage in Patients With Migraine

Completed

NCT05760638

Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)

Completed

NCT06180577

A Survey Study to Assess the Accessibility of the Nerivio Device At School

Completed

NCT05769322

Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in Adolescence

Completed

NCT05940870

A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention.

Completed

NCT04089761Not Applicable

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

Terminated

NCT04161807Not Applicable

Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine

Completed

NCT04194008Not Applicable

Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic Migraine

Completed

NCT04600388

Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine

Completed

All 15 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 15